Clinical trial
Evaluation of clINical reCovery After a Relapse: a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW (INCREASE)
NCT03387046 is registered in ClinicalTrials.gov with Merck KGaA, Darmstadt, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of clINical reCovery After a Relapse: a Pilot Study assEssing the Neuronal Effects of D-Aspartate in RR-MS Subjects Treated With IntErferon Beta 1a 44 mcg TIW (INCREASE)
- Lead sponsor
- Merck KGaA, Darmstadt, Germany
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 26, 2018
- Completion date
- January 11, 2019
- Enrollment
- 7 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.